Effects of Omega 3 in Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-05-31

Study Completion Date

2003-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Omega 3 Fatty Acids on the Vascular Calcification Biomarkers Fetuin A and Osteoprotegerin in Patients With CRF

NCT03982966

Chronic Renal Failure

COMPLETED NA

Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance

NCT01215903

Insulin Resistance Type 2 Diabetes

COMPLETED PHASE2

Vascular Impact of Omega-3 in Metabolic Syndrome

NCT01566188

Essential Hypertension Metabolic Syndrome

COMPLETED NA

Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

NCT01002118

Cardiovascular Disease

TERMINATED NA

Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 Diabetes

NCT05980026

Diabetes Mellitus, Type 1

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis End Stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fish oil supplementation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hemodialysis at least 6 months duration end stage renal disease

Exclusion Criteria

* \- Age \< 18 y ou \> 75 y
* Hemodialysis \< 6 months
* Diabetes, obesity
* allergy to fish
* Asthma
* glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
* erythropoïetin \< 3 months
* Cancer
* Hemoglobin \< 11 g/l
* disease \< 1 month
* pregnancy
* respiratory insufficiency
* intensive sport practice
* refusal

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No